Fri, Jan 30, 2015, 4:06 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • break_thru_99 break_thru_99 May 6, 2013 9:44 AM Flag

    Rejection in EU = get out now while you can longs

    Make no mistake about it, don't delude yourself. This was a rejection. And this isn't coming from a basher, it's coming from someone who had lukewarm support of its being approved in Europe. If you don't believe me just read my prior posts. You don't withdraw an application unless you know that its about to be rejected.
    This stock is very overpriced at this point, to say the least. Compare it to Vivus, a company that currently has its product on market (two products actually, including its ED drug Spedra, which was also recently approved in Europe) and its market price currently stands at 25% LESS than that of Arena. The stock price itself is irrelevant as Arenas shares are simply more dilute. That and the other takeaway from Friday is that Arena has essentially nothing in its own pipeline. If you like Arena, get out now and buy again after it finishes dropping. By all rights this stock should be priced no higher than $6/share at this point, and it may not be long before it is.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.315-0.195(-4.32%)3:59 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.